27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Think you know the markets? See if you can guess this stock by the chart and clues below.
- Rumors surfaced, and were squashed, this week about this company being taken over by Allergan plc (NYSE: AGN).
- The stock hit an all-time high in June of 2015, and has been likened to "the Apple of biotechs".
- Sympathy plays include Pfizer Inc (NYSE: PFE), Johnson & Johnson (NYSE: JNJ) and Bristol-Myers Squibb Co (NYSE: BMY).
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Answer: Gilead Sciences, Inc. (NASDAQ: GILD)
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.